Philip Morris International (PMI) Expands IQOS ILLUMA Series in Convenience Stores

PMI by 2FIRSTS.ai
Jun.01.2023
Philip Morris International (PMI) Expands IQOS ILLUMA Series in Convenience Stores
Philip Morris International (PMI) plans to introduce its HNB product IQOS ILLUMA series to convenience stores nationwide on May 31.

On May 31, Philip Morris International (PMI) announced its plan to introduce its HNB (Heat-Not-Burn) product, IQOS ILLUMA series, into convenience stores. Now, more than 20,000 convenience stores nationwide will be able to purchase the IQOS ILLUMA series products at a discounted price of up to 30,000 Korean won (approximately 162 RMB).

Philip Morris International (PMI) Expands IQOS ILLUMA Series in Convenience Stores
Heating tobacco prices|Image source: 2FIRSTS


Specific discount plan


The plan released this time includes two significant changes.


Firstly, the reward sales and referral program previously available only for IQOS ILLUMA Prime and IQOS ILLUMA products is now also applicable to IQOS ILLUMA One.


In addition, the consumer program that was previously only available at IQOS official stores has now expanded to more than 20,000 convenience stores nationwide, including GS25, CU, Seven Eleven, and others.


Through the use of a trade-in reward sales program, users can purchase IQOS ILLUMA Prime and IQOS ILLUMA at discounted prices of 109,000 South Korean won (approximately 593 Chinese yuan) and 69,000 South Korean won (approximately 377 Chinese yuan) respectively.


The promotional price of IQOS ILLUMA One is 54,000 Korean won (approximately 291 Chinese yuan). However, in order to avail this offer, customers are required to return their old IQOS devices to the official PMI website and register the new device in their own name.


In addition, customers can benefit from product recommendations discounts by referring friends, allowing them to purchase IQOS ILLUMA Prime and IQOS ILLUMA at discounted prices of 119,000 South Korean Won (approximately 645 Chinese Yuan) and 79,000 South Korean Won (approximately 431 Chinese Yuan) respectively. Furthermore, the discounted price for IQOS ILLUMA One is 59,000 South Korean Won (approximately 323 Chinese Yuan).


PMI has joined the price war.


According to recent findings from a survey conducted by the South Korean Ministry of Strategy and Finance, it has been revealed that the domestic tobacco e-cigarette market has significantly increased its share in the overall tobacco market, rising from 2.2% in 2017 to 14.8% in the first half of 2022. This surge in market share can be attributed to the growing popularity of HNB (Heat-Not-Burn) products, which have emerged as a new growth driver in the South Korean tobacco market in recent years.


South Korean domestic company KT&G's Lil accounts for 48% of the market, followed by Philip Morris International's (PMI) IQOS at 42%, and British American Tobacco's (BAT) Glo at 10%. The other two major international tobacco companies, Imperial Tobacco (IMB) and Japan Tobacco (JTI), are essentially absent from the Korean market.


Previously, professionals in the South Korean tobacco market informed the media that British American Tobacco (BAT) was attempting to increase its pod sales in Korea by offering low-priced HNB tobacco products. PMI has also taken a similar approach to lower its market prices, competing for market share by reducing the price of the iQOS ILLUMA series e-cigarette. Korean consumers can now purchase these products at discounted prices in convenience stores nationwide, further stimulating market competition.


As competition intensifies, the future development of the tobacco market is expected to be unpredictable. Consumers in South Korea are likely to continue benefitting from the price advantages resulting from this competition.


Reference: [1] Philip Morris Korea expands IQOS consumer program to convenience stores in Korea. Asia Economic News. May 31, 2023.


We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Pennsylvania Lists 163 Vape Products Eligible for Sale, Including Vuse and JUUL; Previously Pending Chinese Brands Such as OXBAR Remain Absent, While Unlisted Products Including Geek Bar Face Enforcement From October 19
Pennsylvania Lists 163 Vape Products Eligible for Sale, Including Vuse and JUUL; Previously Pending Chinese Brands Such as OXBAR Remain Absent, While Unlisted Products Including Geek Bar Face Enforcement From October 19
Pennsylvania begins enforcing its electronic nicotine delivery system (ENDS) directory restrictions on October 19, 2026. The October 18 directory contained 163 product records from seven manufacturers, including Vuse, JUUL, NJOY, Logic and Naked 100. Geek Bar, RAZ and Lost Mary were absent. BAT, Altria, Japan Tobacco and JUUL collectively accounted for 112 records, or 68.7%, while Imperial Brands' blu had no listings. The directory included 15 disposable vape records, 40 bottled e-liquids and 10 products labeled 0mg, but no open-system refillable devices. Twenty-two manufacturer certifications remained under review. Four Logic models corresponding to Smoore's pending records were listed under the brand owner, while LYCO, OXBAR and Boulder/Rock had no approved directory entries.
Regulations
Oct.19
NAS 2026 | Cliff Douglas: Risk Continuum Should Play a Central Role in Tobacco Policy
NAS 2026 | Cliff Douglas: Risk Continuum Should Play a Central Role in Tobacco Policy
Cliff Douglas, a veteran U.S. tobacco-control and public health policy figure, told NAS 2026 that the “continuum of risk” should play a central role in tobacco policy. He called for clearer market pathways, stronger risk communication, differentiated regulation and enforcement, and said possible FDA reforms to PMTA reviews could be a “welcome correction” if they create a more efficient, predictable route for scientifically substantiated lower-risk products. Read 2Firsts’ on-site coverage.
Sep.26
Product | Juul Labs Launches Upgraded JUUL2 Kit in UK With Four Pods at £9.99 and USB-C Charging
Product | Juul Labs Launches Upgraded JUUL2 Kit in UK With Four Pods at £9.99 and USB-C Charging
Juul Labs UK has introduced an upgraded JUUL2 Starter Kit for the UK market in October 2026, retaining a recommended retail price of £9.99 while doubling the number of included pods from two to four. The kit contains Crisp Menthol, Virginia Tobacco, Mango and Watermelon pods. The updated device replaces the previous proprietary charging dock with a USB-C port and offers longer battery life. The kit also features reduced packaging and retains a two-year limited warranty. Distribution is scheduled through major UK retailers, wholesalers, convenience stores and the JUUL UK website.
product
Oct.15
Why Does JPMorgan Favor BAT Over Philip Morris Despite Forecasting Slower Growth of 3.9% Versus 6.2%?
Why Does JPMorgan Favor BAT Over Philip Morris Despite Forecasting Slower Growth of 3.9% Versus 6.2%?
JPMorgan resumed equity research coverage of British American Tobacco (BAT), Philip Morris International (PMI) and Imperial Brands in November 2026, assigning BAT an Overweight rating and the other two companies Neutral ratings. The bank forecasts like-for-like sales growth of 3.9% for BAT and 6.2% for PMI in 2027, but estimates the two companies will trade at approximately 11 times and 21 times 2027 earnings, respectively. JPMorgan cited BAT's improving position in US nicotine pouches and vaping products as a driver of its investment outlook. BAT reported a 220% constant-currency increase in US modern oral nicotine revenue in the first half of 2026, while PMI's ZYN US shipments returned to growth in the third quarter. Imperial expects NGPs to represent 4% to 5% of sales and has expanded its oral portfolio through acquisitions.
Capital Markets
Nov.12
Former Roche Neuroscience and Rare Diseases Communications Director Ria Kioupritzi Joins PMI as Scientific Affairs Director
Former Roche Neuroscience and Rare Diseases Communications Director Ria Kioupritzi Joins PMI as Scientific Affairs Director
Eleftheria (Ria) Kioupritzi, a biopharmaceutical professional with more than 15 years of experience, has joined Philip Morris International as Director Scientific Affairs within Corporate Affairs. She previously served at Roche as Senior Scientific Communications Director for Neuroscience and Rare Diseases and worked extensively in spinal muscular atrophy. Her earlier career also covered competitive intelligence, clinical and regulatory monitoring, pipeline development and launch preparation. During her time working in Roche's SMA field, Evrysdi passed through several U.S. FDA milestones, including its initial approval, an expanded indication for younger infants and approval of a tablet formulation. Public records do not show that Kioupritzi herself led the FDA submissions.
Sep.22
Special Report|Japan Tobacco Buys CLEW: Can Its 160,000-Store Cigarette Network Help It Vie for U.S. Nicotine Pouch Share Against PMI and BAT?
Special Report|Japan Tobacco Buys CLEW: Can Its 160,000-Store Cigarette Network Help It Vie for U.S. Nicotine Pouch Share Against PMI and BAT?
Japan Tobacco Inc. (JT) announced on November 12, 2026, that it had acquired the U.S. assets of nicotine pouch brand CLEW from Nevcore Innovations Inc., including trademarks, intellectual property, product formulations and a Premarket Tobacco Product Application (PMTA). CLEW, currently distributed through selected outlets in 13 U.S. states, will immediately join the JTI LIGGETT portfolio. The transaction follows JT's approximately $2.4 billion acquisition of U.S. cigarette maker Vector Group in 2024. JTI LIGGETT says its existing cigarette brands reach more than 160,000 U.S. retail stores. During the 2026 NACS Show in October, JTI LIGGETT booth staff told 2Firsts that the company had not yet launched nicotine pouches in the United States. Although Nevcore previously announced FDA acceptance of CLEW's PMTA, the brand is absent from the agency's current list of authorized nicotine pouch products. JT has not disclosed a retail expansion plan for CLEW.
Business
Nov.12